What are you searching for?

23.11.2021 | Insight

ICM: An intensive specialism looking for institutional support

By Adam Doggett

Close up of intensive care patient's hand

On the 4th November 2021, the professional and statutory body for intensive care medicine specialists in the UK, The Faculty of Intensive Care Medicine (FICM), published FFICM Final OSCE (Objective Structured Clinical Examination)/ SOE (structured oral exam) results. A successful pass of both parts of the exam is required for healthcare professionals (HCPs) to move through the Intensive Care Medicine (ICM) training pathway. 

The examination, designed to test practical clinical competence, including effective application of clinical science knowledge and skills in safe practice, returned less than inspiring results. Among the trainee cohort, 28% and 67% pass rate in OSCE and SOE components respectively warranted an FICM investigation into “initial concern with the exam results” which resulted in a delay to the publication of results and in turn, an official statement addressing the delay.

As intensive care medicine specialists and trainees from across the pathway took to Twitter to bemoan the outcome, any suggestion that COVID-19 could be blamed for the poor results was swiftly swept aside, with HCPs considering the pandemic to be an inconvenience to learning rather than an education deal-breaker.

With COVID-19 avoiding blame, HCPs turned to FCIM to take the brunt of the dissatisfaction. The predominant view of those working in the field was that the examination system, rather than the candidates, lacked the required quality to produce intensive care medicine specialists. 

With so many candidates failing to make the grade, FCIM runs the risk of leaving future ICM specialists disenfranchised and let-down by the system. Trainee Rachel Ward epitomised feelings of falling victim to the exam, describing how their efforts have been “thrown back in our face”. 

There is a feeling from previous exam candidates that content being covered may have changed over the years as the FCIM looks for the best way to make sure intensive care specialists are adequately trained and of high quality before continuing through the pathway.

However, the higher the standards, the greater the barrier to entry and the reflections of Thom Hall offer notable insight into the struggles of an already understaffed specialty.

While some may be put off going through the training and joining the specialism, the pressures of the profession causes others, who already have ICM credentials, to change course. Emily’s experience is all too common and extends across healthcare roles, as reported by a recent CREATION.co study to investigate views towards, and reception of UK health policies. The research identified work/life balance as one of the primary areas where HCPs looked for greater support and protection from the system in which they work.

Rigorous examination which only allows suitable candidates entry to the next phase of training whilst simultaneously not discounting competent trainee physicians seems a tough balance to strike. While many have been quick to blame FCIM for staffing an institutional failure, there is a sense of sympathy for an organisation ultimately working to achieve the best outcomes for patients in the most critical of situations. There is a solution to be found and that solution will come through collaboration and humility.

For more information on how CREATION.co can support you with your healthcare challenges and to better understand healthcare professionals get in touch at contact@creation.co, we’d love to help.

View all articles >

Meet the Author

Adam Doggett

As Head of Analytics Solutions, Adam brings an innovative perspective to solving bespoke client challenges and developing methodologies, helping our clients get the most value from their data and overcome the healthcare challenges they face. Adam enjoys acting and cycling, but interestingly not at the same time.

Suggested next


A CREATION Press Release

02.07.2013 | Press Release

Tamoxifen dominates UK doctors’ online talk on breast cancer treatment

Tamoxifen dominates UK doctors’ online talk on breast cancer treatment

12.11.2019 | Article

HCPs engage with Top 50 pharma around good and bad news

HCPs engage with Top 50 pharma around good and bad news

By Mary Kangley

View all articles >